论文部分内容阅读
弥漫性甲状腺肿伴甲状腺功能亢进症(Graves病)为我国常见病,抗甲充药物治疗并非去除病因,故临床虽已明显好转,甲功(T_3、T_4、TSH等)恢复正常,维持多久才可停药仍为难题。我们对Graves病患者进行了促甲状腺激素受体抗体(TRAb)测定,并在此基础上探讨其临床意义。
Diffuse goiter with hyperthyroidism (Graves disease) is a common disease in our country, anti-drug therapy is not to remove the cause, so although the clinical manifestations have improved significantly, A Gong (T_3, T_4, TSH, etc.) returned to normal, Drug withdrawal is still a problem. We conducted thyrotropin-receptor-antibody (TRAb) assays in patients with Graves disease and explored its clinical implications.